Indian Supreme Court Questions Pharma Firm Over Deaths Linked to Cough Syrup

Learn why the Indian Supreme Court is letting a case proceed against a pharma firm linked to child deaths in Uzbekistan from cough syrup.

#PharmaDeaths, #Uzbekistan, #SupremeCourtIndia, #CoughSyrup, #DrugSafety

https://newsletter.tf/indian-supreme-court-allows-case-pharma-firm-uzbekistan-child-deaths/

The Supreme Court is allowing a case against a pharma company linked to over 18 child deaths in Uzbekistan. The court said the company hurt India's good name.

#PharmaDeaths, #Uzbekistan, #SupremeCourtIndia, #CoughSyrup, #DrugSafety

https://newsletter.tf/indian-supreme-court-allows-case-pharma-firm-uzbekistan-child-deaths/

Indian Supreme Court Allows Case Against Pharma Firm Over Uzbekistan Child Deaths

Learn why the Indian Supreme Court is letting a case proceed against a pharma firm linked to child deaths in Uzbekistan from cough syrup.

Debate Over Drug Advertisements to Consumers Intensifies

Ads for medicines shown to people are being talked about a lot. Learn why some people like them and others worry about them. The US is one of few countries that allows this.

#MedicineAds, #HealthNews, #USHealth, #DrugSafety, #ConsumerAwareness

https://newsletter.tf/medicine-ads-talk-us/

People Talk About Ads for Medicines

Ads for medicines shown to people are being talked about a lot. Learn why some people like them and others worry about them. The US is one of few countries that allows this.

Ads that show medicines directly to people are a big topic. Some think they help people learn about health. Others worry they might make drugs cost more or be used the wrong way. The US is one of only a few countries that allows these ads.

#MedicineAds, #HealthNews, #USHealth, #DrugSafety, #ConsumerAwareness

https://newsletter.tf/medicine-ads-talk-us/

People Talk About Ads for Medicines

Ads for medicines shown to people are being talked about a lot. Learn why some people like them and others worry about them. The US is one of few countries that allows this.

#Evidence that #statins are safer than thought. Safety surveillance data are important to identify rare risks that have been missed in clinical trials. Without #placebo controls, however, events can easily be falsely attributed to a certain treatment, just because they happen at a similar time but without a causal relationship. #drugsafety #drugs

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01578-8/fulltext

CDSCO flags 167 drug samples as Not of Standard Quality (NSQ) in December, including spurious drugs. Learn about the latest drug safety alerts and regulatory actions. https://english.mathrubhumi.com/news/india/cdsco-drug-quality-alert-december-h3iajdl6?utm_source=dlvr.it&utm_medium=mastodon #CDSCO #DrugSafety #NSQDrugs #MedicineQuality #PharmaNews

🚨 Tin nhanh: Bộ Y tế quyết định tiêu hủy lô thuốc giảm đau, chống viêm không đạt chất lượng. Lô thuốc không đáp ứng tiêu chuẩn an toàn, gây nguy cơ cho người dùng; quy trình tiêu hủy được thực hiện nghiêm ngặt để bảo vệ sức khỏe cộng đồng. #health #an_toan #thuoc #Vietnam #BảnTinTrưa #tiêuhủy #pharmacy #drugSafety

https://vietnamnet.vn/ban-tin-trua-21-01-tieu-huy-lo-thuoc-giam-dau-chong-viem-khong-dat-chat-luong-2483848.html

Bản tin trưa 21/01: Tiêu hủy lô thuốc giảm đau, chống viêm không đạt chất lượng

Bản tin trưa 21/01: Tiêu hủy lô thuốc giảm đau, chống viêm không đạt chất lượng; Ông Trump thừa nhận mắc sai sót khi trấn áp nhập cư; Châu Âu ngừng phê chuẩn thỏa thuận thương mại với Mỹ

Vietnamnet.vn

New lawsuits claim Ozempic and other GLP-1 drugs may be linked to NAION-related vision loss. Patients allege unexpected blindness risks. Read More Here: https://www.jdsupra.com/legalnews/ozempic-blindness-lawsuits-legal-claims-1081107/
#Ozempic #GLP1 #NAION #VisionLoss #DrugSafety #PharmaNews

https://www.jdsupra.com/legalnews/ozempic-blindness-lawsuits-legal-claims-1081107/

Ozempic Blindness Lawsuits: Legal Claims Allege GLP-1 Drugs Linked to NAION Vision Loss | JD Supra

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for type 2 diabetes and weight...

JD Supra
Fake and substandard medicines are rapidly increasing in India, with thousands of drug samples failing safety standards nationwide. https://english.mathrubhumi.com/news/kerala/india-fake-substandard-medicines-crisis-iwadffuz?utm_source=dlvr.it&utm_medium=mastodon #FakeMedicines #CounterfeitDrugs #PublicHealthIndia #DrugSafety
The Centre has banned the manufacture and sale of oral formulations containing nimesulide above 100 mg, citing serious health risks and availability of safer alternatives, according to a notification. https://english.mathrubhumi.com/lifestyle/health/centre-bans-popular-painkiller-nimesulide-above-100-mg-n9ghhi0c?utm_source=dlvr.it&utm_medium=mastodon #Nimesulide #PainkillerBan #HealthMinistry #DrugSafety #ICMR